333 related articles for article (PubMed ID: 28401034)
1. Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development.
Aguisanda F; Thorne N; Zheng W
Curr Chem Genom Transl Med; 2017; 11():1-18. PubMed ID: 28401034
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.
Porto AF
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():125-32. PubMed ID: 25345094
[TBL] [Abstract][Full Text] [Related]
3. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.
Fasano T; Pisciotta L; Bocchi L; Guardamagna O; Assandro P; Rabacchi C; Zanoni P; Filocamo M; Bertolini S; Calandra S
Mol Genet Metab; 2012 Mar; 105(3):450-6. PubMed ID: 22227072
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.
Tylki-Szymańska A; Jurecka A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):99-106. PubMed ID: 24798600
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal Acid Lipase Deficiency in 23 Spanish Patients: High Frequency of the Novel c.966+2T>G Mutation in Wolman Disease.
Ruiz-Andrés C; Sellés E; Arias A; Gort L;
JIMD Rep; 2017; 37():7-12. PubMed ID: 28220406
[TBL] [Abstract][Full Text] [Related]
7. Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals.
Ries S; Büchler C; Schindler G; Aslanidis C; Ameis D; Gasche C; Jung N; Schambach A; Fehringer P; Vanier MT; Belli DC; Greten H; Schmitz G
Hum Mutat; 1998; 12(1):44-51. PubMed ID: 9633819
[TBL] [Abstract][Full Text] [Related]
8. Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
Civallero G; De Mari J; Bittar C; Burin M; Giugliani R
Gene; 2014 Apr; 539(1):154-6. PubMed ID: 24508470
[TBL] [Abstract][Full Text] [Related]
9. [Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].
Tanaka A
Nihon Rinsho; 1995 Dec; 53(12):3004-8. PubMed ID: 8577049
[TBL] [Abstract][Full Text] [Related]
10. A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.
Ries S; Aslanidis C; Fehringer P; Carel JC; Gendrel D; Schmitz G
J Lipid Res; 1996 Aug; 37(8):1761-5. PubMed ID: 8864960
[TBL] [Abstract][Full Text] [Related]
11. A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease.
Dairaku T; Iwamoto T; Nishimura M; Endo M; Ohashi T; Eto Y
Mol Genet Metab; 2014 Feb; 111(2):193-6. PubMed ID: 24295952
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage.
Du H; Duanmu M; Witte D; Grabowski GA
Hum Mol Genet; 1998 Sep; 7(9):1347-54. PubMed ID: 9700186
[TBL] [Abstract][Full Text] [Related]
13. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
Aslanidis C; Ries S; Fehringer P; Büchler C; Klima H; Schmitz G
Genomics; 1996 Apr; 33(1):85-93. PubMed ID: 8617513
[TBL] [Abstract][Full Text] [Related]
14. Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics.
Aguisanda F; Yeh CD; Chen CZ; Li R; Beers J; Zou J; Thorne N; Zheng W
Orphanet J Rare Dis; 2017 Jun; 12(1):120. PubMed ID: 28659158
[TBL] [Abstract][Full Text] [Related]
15. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.
Pagani F; Pariyarath R; Garcia R; Stuani C; Burlina AB; Ruotolo G; Rabusin M; Baralle FE
J Lipid Res; 1998 Jul; 39(7):1382-8. PubMed ID: 9684740
[TBL] [Abstract][Full Text] [Related]
16. Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease.
Du H; Sheriff S; Bezerra J; Leonova T; Grabowski GA
Mol Genet Metab; 1998 Jun; 64(2):126-34. PubMed ID: 9705237
[TBL] [Abstract][Full Text] [Related]
17. Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease.
Chuang JC; Lopez AM; Posey KS; Turley SD
Biochem Biophys Res Commun; 2014 Jan; 443(3):1073-7. PubMed ID: 24370824
[TBL] [Abstract][Full Text] [Related]
18. Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice.
Du H; Cameron TL; Garger SJ; Pogue GP; Hamm LA; White E; Hanley KM; Grabowski GA
J Lipid Res; 2008 Aug; 49(8):1646-57. PubMed ID: 18413899
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice.
Du H; Heur M; Witte DP; Ameis D; Grabowski GA
Hum Gene Ther; 2002 Jul; 13(11):1361-72. PubMed ID: 12162818
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
